Risk factor
Low price volatility
Profitability factor
Weak margins and returns
About
Almirall, S.A., a biopharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines in Europe, the United States, and internationally. The company offers its products for dermatological diseases comprising actinic keratosis, atopic dermatitis, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, acne, and orphan indications, as well as for cardiovascular, musculo-skeletal, respiratory, and nervous...
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITDA, un
Target Price
The average target price of ALM.MC is 14 and suggests 6% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation s
Buy
Sell